Cargando…

A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma

Long non-coding RNAs (lncRNAs) have been considered as biomarkers for the carcinogenesis and development of various cancers. However, the prognostic significance of lncRNAs in renal cell carcinoma (RCC) remains unclear. This study aimed to determine the predictive ability of lncRNAs in clear cell RC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Haoran, Ye, Tao, Yang, Xiaoqi, Lv, Peng, Wu, Xiaoliang, Zhou, Hui, Zeng, Jin, Tang, Kun, Ye, Zhangqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196268/ https://www.ncbi.nlm.nih.gov/pubmed/32368310 http://dx.doi.org/10.7150/jca.40421

Ejemplares similares

LncRNA BLACAT1 May Serve as a Prognostic Predictor in Cancer: Evidence from a Meta-Analysis
por: Lu, Hongyan, et al.
Publicado: (2019)

LncRNAs Expression Signatures of Renal Clear Cell Carcinoma Revealed by Microarray
por: Yu, Gan, et al.
Publicado: (2012)

lncRNA PVT1 and its splicing variant function as competing endogenous RNA to regulate clear cell renal cell carcinoma progression
por: Yang, Tao, et al.
Publicado: (2017)

Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma
por: Ma, Wei, et al.
Publicado: (2021)

A Metastasis-Related lncRNA Signature Correlates With the Prognosis in Clear Cell Renal Cell Carcinoma
por: Dou, Qian, et al.
Publicado: (2021)

Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis
por: Xue, Sheng, et al.
Publicado: (2022)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Ferroptosis-associated lncRNA prognostic signature predicts prognosis and immune response in clear cell renal cell carcinoma
por: Lai, Jiayi, et al.
Publicado: (2023)

A novel oxidative-stress related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma
por: Zhang, Huo, et al.
Publicado: (2019)

A Computationally Constructed lncRNA-Associated Competing Triplet Network in Clear Cell Renal Cell Carcinoma
por: Zhang, Hui, et al.
Publicado: (2022)

Construction and Characterization of n6-Methyladenosine-Related lncRNA Prognostic Signature and Immune Cell Infiltration in Kidney Renal Clear Cell Carcinoma
por: Chen, Zerong, et al.
Publicado: (2022)

A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma
por: Xie, Xiaozai, et al.
Publicado: (2021)

Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma
por: Li, Tinghao, et al.
Publicado: (2022)

A Notch signaling-related lncRNA signature for predicting prognosis and therapeutic response in clear cell renal cell carcinoma
por: Zhang, Lulu, et al.
Publicado: (2023)

A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma
por: Zhang, Zedan, et al.
Publicado: (2021)

A four-gene signature predicts survival in clear-cell renal-cell carcinoma
por: Dai, Jun, et al.
Publicado: (2016)

Comprehensive analysis of lncRNA biomarkers in kidney renal clear cell carcinoma by lncRNA-mediated ceRNA network
por: Gong, Ke, et al.
Publicado: (2021)

A novel necroptosis-related lncRNAs signature for survival prediction in clear cell renal cell carcinoma
por: Zhao, Liwen, et al.
Publicado: (2022)

A novel coagulation-related lncRNA predicts the prognosis and immune of clear cell renal cell carcinoma
por: Wu, Wensong, et al.
Publicado: (2023)

A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer
por: Zhou, Hui, et al.
Publicado: (2015)

A Novel Tumor Mutation Burden Related lncRNA Signature Identified Prognosis and Tumor Immune Microenvironment Features in Clear Cell Renal Cell Carcinoma
por: Lin, Lin, et al.
Publicado: (2023)

The lncRNA Signatures of Genome Instability to Predict Survival in Patients with Renal Cancer
por: Huang, Liang, et al.
Publicado: (2021)

Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma
por: Sun, Jian-Xuan, et al.
Publicado: (2021)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
por: Bai, Zhixun, et al.
Publicado: (2022)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023)

LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p
por: Ye, Zhuo, et al.
Publicado: (2019)

Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma
por: Yu, JunJie, et al.
Publicado: (2021)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma
por: Zhang, Yue, et al.
Publicado: (2022)

Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis
por: Liu, Haoran, et al.
Publicado: (2020)

Screening for the Key lncRNA Targets Associated With Metastasis of Renal Clear Cell Carcinoma
por: Liu, Huibin, et al.
Publicado: (2016)

LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma
por: Xiao, Haibing, et al.
Publicado: (2015)

A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients
por: Shen, Cheng, et al.
Publicado: (2022)

Identification and validation of fatty acid metabolism-related lncRNA signatures as a novel prognostic model for clear cell renal cell carcinoma
por: Shen, Cheng, et al.
Publicado: (2023)

Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma
por: Lin, Hang, et al.
Publicado: (2023)

Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis
por: Liu, Haoran, et al.
Publicado: (2020)

Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis: Erratum
por: Liu, Haoran, et al.
Publicado: (2022)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

LncRNA NORAD as a Novel Predictor of Lymph Node Metastasis and Prognosis in Solid Tumors: A Systematic Review and Meta-Analysis
por: Ye, Tao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_levpegjh45mqopj6b1579v5car